Matej Štepianský
Matej Štepianský is a public relations specialist at Dôvera, a private health insurance company in Slovakia, who recently addressed the legal challenges surrounding the reimbursement of the medication Voxzogo, which is used to treat achondroplasia. He emphasized that the responsibility for determining which medications are covered by public health insurance lies with the state, not the insurers, and has highlighted the ongoing negotiations between the Ministry of Health and the drug's registration holder to make this treatment accessible to patients in Slovakia.
Not in the pool (under ¢1).
Recent news mentions
Matej Štepiansky, spokesperson for Dôvera, emphasizes the importance of expert discussion before voting on funding.
Cukrovkárom zachraňujú život. Štát aj poisťovne mlčia, či zvýšia príspevok na senzory
Slovakia· 2025-09-23
Matej Štepiansky is a PR specialist at the insurance company Dôvera who stated that the new contract will improve conditions for the hospital.
Nemocnica v Bojniciach sa dohodla s Dôverou, nová zmluva má garantovať kratšie čakacie - SMESlovakia· 2025-07-31
Matej Štepiansky is the PR specialist for Dôvera who expressed the company's intention to negotiate with the hospital.
Dôvera považuje výpoveď za nekorektnú, s nemocnicou v Bojniciach sa chce dohodnúť - SMESlovakia· 2025-05-31
Matej Štepiansky explained the issues surrounding the processing of ePrescriptions by non-contracted healthcare providers.
Ministerstvo chystá zmenu legislatívy k eReceptom, podľa Dôvery problém s nimi nevyriešiSlovakia· 2025-05-22
Matej Štepiansky is the PR specialist for Dôvera who discussed the ongoing negotiations with the hospital.
Nemocnica v Bojniciach má na dosah prvú dohodu. Nevýhodné zmluvy s poisťovňami neuzavrie - SMESlovakia· 2025-05-02
Matej Štepianský is a PR specialist for the health insurance company Dôvera.
Generálna prokuratúra podala 12 správnych žalôb pre nesúhlas poisťovní o preplatenie liekuSlovakia· 2025-04-17